• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

Corticosteroid foam moves beyond scalp psoriasis

Maui, Hawaii - Already FDA-approved for scalp psoriasis, clobetasol propionate foam is effective against mild to moderate psoriasis in other parts of the body as well.

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 expert is featured in this series.
Related Content
POLL: What Topics and Content Would You Like to See More of From Us?
January 20th 2025

POLL: What Topics and Content Would You Like to See More of From Us?

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
August 2nd 2024

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

When and How to Employ the Buy and Bill Model
January 20th 2025

When and How to Employ the Buy and Bill Model

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
July 1st 2024

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

Insights from a Dermatologist with Urticaria
January 20th 2025

Insights from a Dermatologist with Urticaria

Top 5 Articles of the Week: January 12-17
January 19th 2025

Top 5 Articles of the Week: January 12-17

© 2025 MJH Life Sciences

All rights reserved.